We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Oxygen Controller Assists Newborns Needing Mechanical Ventilation

By HospiMedica International staff writers
Posted on 15 Jun 2010
A new automatic oxygen controller provides accurate and reliable oxygen saturation (SpO2) measurements, even under challenging clinical conditions. More...


The Closed Loop Controller of Inspired Oxygen (CLiO2) system noninvasively and continuously measures the oxygen level in a newborn's blood using the well known Masimo SET measure-through motion and low perfusion pulse oximetry technology. The CLiO2 system processes blood oxygen saturation levels by a computer algorithm that then anticipates trends, and modifies the amount of oxygen delivered. If necessary, adjustments can be made on a second to second basis, an accuracy level not currently possible with manual control. The CLiO2 is a product of CareFusion (San Diego, CA, USA), and is currently available in most Western European and Asian countries.

"If oxygen levels become either too high or too low for premature babies on ventilation they are at risk for serious complications such as permanent eye or chronic lung damage,” said Steven Donn, M.D., a professor of pediatrics in the division of neonatal-perinatal medicine at the University of Michigan Health System (Ann Arbor, USA). "I have been very impressed with how much more stable oxygen levels become with the CLiO2 system compared to what we've used in the past.”

"We built the CLiO2 system to address a worldwide medical need to improve the way newborns are cared for in hospitals,” said David Schlotterbeck, chairman and CEO of CareFusion. "We hope this system will help reduce complications associated with newborns needing mechanical ventilation and can free up time for clinicians to better care for some of their most vulnerable patients.”

Conventional pulse oximetry assumes that arterial blood is the only blood pulsating in the measurement site. However, during patient motion, the venous blood also moves, which causes conventional pulse oximetry to under-read because it cannot distinguish between the arterial and venous blood. The Masimo (Irvine, CA, USA) SET signal processing identifies the venous blood signal, isolates it, and using adaptive filters, cancels the noise and extracts the arterial signal. It then reports the true arterial oxygen saturation and pulse rate. More than 100 independent and objective peer-reviewed clinical studies document the significantly superior performance of Masimo SET Pulse Oximetry.

Related Links:

CareFusion
Masimo



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.